The bonds are divided into three tranches where
The bond issue generated strong investor interest and was oversubscribed.
The bonds will be listed on Nasdaq Stockholm.
Nordea and SEB acted as lead managers on the transaction. Mannheimer Swartling Advokatbyrå acted as legal adviser to Sobi.
Sobi
Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Providing reliable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 1,800 employees across
Contacts
For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media contacts, click here.
Head of Investor Relations
https://news.cision.com/swedish-orphan-biovitrum-ab/r/sobi-has-completed-sek-3-billion-senior-bond-issue,c3975776
https://mb.cision.com/Public/14266/3975776/a6ee3a295140c786.pdf
(c) 2024 Cision. All rights reserved., source